Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
BCAL Diagnostics Limited ( (AU:BDX) ) just unveiled an announcement.
BCAL Diagnostics Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, highlighting its commitment to transparency and accountability in its operations.
More about BCAL Diagnostics Limited
BCAL Diagnostics Limited operates in the healthcare industry, focusing on diagnostic solutions. The company is known for developing innovative diagnostic technologies aimed at improving health outcomes.
Average Trading Volume: 153,667
Technical Sentiment Signal: Sell
Current Market Cap: A$23.42M
For detailed information about BDX stock, go to TipRanks’ Stock Analysis page.